Approval · Notice of Compliance 36324 · 2025
MICRO +4 REGULAR STRENGTH: Notice of Compliance 36324
Issued November 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36324
- Date
- November 4, 2025
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a primary container closure system
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO +4 REGULAR STRENGTH | Not yet assigned | — |
Medicinal ingredients
- CHROMIC CHLORIDE 4 MCG per ML
- CUPRIC SULFATE 0.4 MG per ML
- MANGANESE SULFATE 0.1 MG per ML
- ZINC SULFATE 1 MG per ML